Skip to main content

Reformulating patient stratification for targeting interventions by accounting for severity of downstream outcomes resulting from disease onset: a case study in sepsis.

Journal of the American Medical Informatics Association : JAMIA2025-03-24PubMed
Total: 74.5Innovation: 8Impact: 7Rigor: 7Citation: 8

Summary

Across two ICU cohorts, the estimated effect of sepsis on mortality was only weakly correlated with predicted sepsis onset risk, and high-risk groups overlapped by 53–67% depending on the site. Incorporating the mortality effect into stratification identified a different, older population than risk-only approaches, indicating that risk-only targeting may miss high-impact intervention candidates.

Key Findings

  • Sepsis risk and estimated mortality effect were weakly correlated (Spearman 0.35 at U-M; 0.31 at BIDMC).
  • High-risk patients overlapped by 66.8% (U-M) and 52.8% (BIDMC) between risk-only versus risk+effect stratification.
  • Including mortality effect identified an older population than risk-only stratification.
  • Among sepsis cases, mortality occurred in 21.9% (U-M) and 26.3% (BIDMC).

Clinical Implications

Decision support should incorporate both disease risk and estimated impact on outcomes (e.g., mortality) when prioritizing alerts and resources, potentially improving yield and equity of sepsis interventions.

Why It Matters

This study challenges risk-only triage by demonstrating that incorporating downstream outcome severity alters who is prioritized for intervention. It provides a scalable framework with immediate relevance to AI-driven sepsis alerts and resource allocation.

Limitations

  • Retrospective observational design with potential unmeasured confounding.
  • Effect estimation details and generalizability beyond ICU settings may be limited.

Future Directions

Prospective evaluation of effect-aware targeting on clinical outcomes and cost-effectiveness; integration with causal inference frameworks and fairness metrics in deployment.

Study Information

Study Type
Cohort
Research Domain
Prognosis
Evidence Level
III - Retrospective multi-cohort analysis with external validation.
Study Design
OTHER